Featuring posters, powerpoints and more
2023 Neuro-Oncology journal publication: NLG2105 phase 1 trial (NCT02502708)
2023 American Association for Cancer Research Poster: Immune responses after starting immunotherapy
2022 Society for Neuro-Oncology Presentation: NLG2105 phase 1 trial, 5-year outcome data
Summary Abstract for the 2022 Society for Neuro-Oncology Presentation